Enters into Cooperation Agreement with Altai CapitalBoard to Seek Shareholder Approval for Declassification at the 2026 Annual Meeting BETHLEHEM, ...
Learn more Investors who take an interest in OraSure Technologies, Inc. (NASDAQ:OSUR) should definitely note that the Independent Director, Steven Boyd, recently paid US$3.00 per share to buy US$225k ...
BETHLEHEM, Pa.- OraSure Technologies (OTI) continues to pin its hopes on the future in the wake of another challenging quarter. The maker of at-home diagnostic tests and sample management solutions ...
BETHLEHEM, Pa. - OraSure Technologies Inc., a maker of diagnostic tests, reported second-quarter revenue of $85.4 million, exceeding the company's own forecast and the consensus estimate of Wall ...
BETHLEHEM, Pa., May 06, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its ...
May 6, 2026, 5 p.m. ET President and Chief Executive Officer — Carrie Eglinton Manner Chief Financial Officer — Kenneth J. McGrath Total Revenue -- $27.9 million, representing a 4% sequential increase ...
OraSure (OSUR) ticked higher by 0.3% after entering a cooperation pact with activist Altai Capital and naming John D. Bertrand to its board. As part of the agreement, Altai will withdraw its director ...
On April 12, 2024, OraSure Technologies, Inc. (“OraSure”) filed a notice with the Securities and Exchange Commission after discovering that an unauthorized party was able to gain access to its ...
BETHLEHEM — OraSure Technologies and drugmaker AbbVie have agreed to end an agreement under which the companies have been co-promoting OraSure’s OraQuick HCV Rapid Antibody Test in the U.S. The ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
NEW YORK – OraSure Technologies Inc. stock extended its fall Tuesday after reports surfaced late last week about a spike in false positive results in San Francisco and New York from its rapid, oral ...
Those are the three steps involved in the InteliSwab, the name of the long-awaited COVID-19 rapid test developed by Bethlehem’s OraSure Technologies Inc. that has now received emergency use ...